Decision-making, Financial Risk Aversion, and Behavioral Biases: The Role of Testosterone and Stress
Overview
Affiliations
We examine the relation between testosterone, cortisol, and financial decisions in a sample of naïve investors. We find that testosterone level is positively related to excess risk-taking, whereas cortisol level is negatively related to excess risk-taking (correlation coefficient [r]: 0.75 and -0.21, respectively). Additionally, we find support for the dual-hormone hypothesis in a financial context. Specifically, the testosterone-to-cortisol ratio is significantly related to loss aversion. Individuals with a higher ratio are 3.4 times more likely to sell losing stocks (standard error [SE]: 1.63). Furthermore, we find a positive feedback loop between financial success, testosterone, and cortisol. Specifically, financial success is significantly related to higher post-trial testosterone and cortisol by a factor of 0.53 (SE: 0.14). Finally, we find that in a competitive environment, testosterone level increases significantly, leading to greater risk-taking than in noncompetitive environment. Overall, this study underscores the importance of the endocrine system on financial decision-making. The results of this study are relevant to a broad audience, including investors looking to optimize financial performance, industry human resources, market regulators, and researchers.
Gendered Consequences of COVID-19 Among Professional Tennis Players.
Cary M, Stephens H J Sports Econom. 2024; 24(2):241-266.
PMID: 38603132 PMC: 9420736. DOI: 10.1177/15270025221120591.
Mapping the knowledge domain of financial decision making: A scientometric and bibliometric study.
Guo L, Cheng J, Zhang Z Front Psychol. 2022; 13:1006412.
PMID: 36337546 PMC: 9627155. DOI: 10.3389/fpsyg.2022.1006412.
Real-time extended psychophysiological analysis of financial risk processing.
Singh M, Xu Q, Wang S, Hong T, Ghassemi M, Lo A PLoS One. 2022; 17(7):e0269752.
PMID: 35877608 PMC: 9312384. DOI: 10.1371/journal.pone.0269752.
Berends Y, Tulen J, Wierdsma A, de Rijke Y, Kushner S, van Marle H Compr Psychoneuroendocrinol. 2022; 8:100080.
PMID: 35757666 PMC: 9216378. DOI: 10.1016/j.cpnec.2021.100080.
Harrison S, Davies N, Howe L, Hughes A Sci Adv. 2021; 7(31).
PMID: 34321204 PMC: 8318368. DOI: 10.1126/sciadv.abf8257.